[Management of hirsutism using cyproterone acetate].
D000085:Acetates / Q000627:therapeutic use; D000328:Adult; D000726:Androgen Antagonists; D004964:Estriol / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000188:drug therapy*; D006801:Humans; D008593:Menopause; D008598:Menstruation / Q000187:drug effects; D008875:Middle Aged; D011372:Progestins / Q000627:therapeutic use
D000085:Acetates; D000726:Androgen Antagonists; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D011372:Progestins; D004997:Ethinyl Estradiol; D004964:Estriol
Behandlung des Hirsutismus mit Cyproteronacetat.